Max India Limited has notified the stock exchanges about its upcoming participation in an investor conference organized by DAM Capital. The company filed the intimation on March 18, 2026, under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.

Conference Details

The company officials will participate in the DAM Capital Hospitals & Diagnostics Conference 2026 scheduled for March 23, 2026. The meetings are planned to commence at 10:00 am onwards and will be held in Mumbai.

Meeting Guidelines

Max India Limited has clarified that all discussions during the investor interactions will be based exclusively on publicly available information. The company has specifically stated that no unpublished price sensitive information (UPSI) is intended to be discussed during these meetings.

Administrative Notes

The company has indicated that changes to the schedule may occur due to exigencies on the part of either the host or the company. The disclosure has been made available on Max India Limited's official website at www.maxindia.com for public access.

The intimation was signed by Trapti, who serves as the Company Secretary and Compliance Officer for Max India Limited. This regulatory filing ensures transparency and compliance with SEBI's disclosure requirements for investor meetings.

Max India Limited announced its consolidated unaudited financial results for the quarter and nine months ended December 31, 2025, showing mixed performance with revenue growth but continued operational losses. The Board of Directors approved these results on February 10, 2026, following a limited review by statutory auditors. Subsequently, the company hosted an earnings conference call with investors and analysts to discuss the quarterly performance.

Financial Performance Overview

The company's financial performance for Q3 FY26 demonstrated both challenges and improvements compared to the previous year:

Nine-Month Performance Analysis

For the nine months ended December 31, 2025, Max India reported comprehensive financial metrics:

Segment-Wise Revenue Performance

The company's business segments showed varied performance during Q3 FY26:

The Assisted Care segment demonstrated significant growth, while the Senior Living segment showed modest improvement. However, the Business Investments segment experienced a notable decline.

Earnings Conference Call and Investor Communication

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Max India hosted an earnings conference call with investors and analysts on February 10, 2026. The senior management discussed the company's performance for Q3 & 9M FY26 ended December 31, 2025. The audio recording of the earnings conference call has been uploaded on the company's website and can be accessed at the provided weblink.

Legal and Regulatory Matters

The company's joint venture, Contend Builders Private Limited (CBPL), continues to address regulatory challenges regarding its Noida projects. CBPL has paid approximately ₹176 crores to the Noida Authority, clearing all outstanding dues. Following Supreme Court proceedings on January 28, 2026, CBPL filed a fresh application for Occupancy Certificate on January 29, 2026, with the next hearing scheduled for February 19, 2026.

Capital Structure and Financial Position

Max India reported basic and diluted earnings per share of ₹(8.17) for Q3 FY26, compared to ₹(10.03) in Q3 FY25. The company's paid-up equity share capital stood at ₹52.45 crores as of December 31, 2025. The rights issue proceeds of ₹124.23 crores are being utilized as planned, with ₹64.93 crores remaining unutilized and temporarily parked in fixed deposits with scheduled commercial banks.